Character Biosciences and Bausch + Lomb announced a partnership to develop innovative treatments for age-related macular degeneration (AMD). The collaboration aims to leverage genetics-guided drug discovery and Bausch + Lomb's extensive expertise in ophthalmology to drive novel drug development.